Reduction of the electrocardiographic QT interval
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 8, 2007
Grant Date -
Feb 19, 2004
app pub date -
Sep 12, 2001
filing date -
Sep 12, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the OTc interval and the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the risk of sudden death or `dead in bed` syndrome; particularly in patients suffering from IDDM.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully